Last reviewed · How we verify

levothyroxin — Competitive Intelligence Brief

levothyroxin (levothyroxin) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

marketed THAP domain-containing protein 1, Macrophage migration inhibitory factor, Malate dehydrogenase, mitochondrial Oncology Small molecule Live · refreshed every 30 min

Target snapshot

levothyroxin (levothyroxin) — Ain Shams University.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
levothyroxin TARGET levothyroxin Ain Shams University marketed THAP domain-containing protein 1, Macrophage migration inhibitory factor, Malate dehydrogenase, mitochondrial
Synthroid levothyroxine Generic (originally multiple — AbbVie/Synthroid) marketed Thyroid hormone THAP domain-containing protein 1, Macrophage migration inhibitory factor, Malate dehydrogenase, mitochondrial 2002-08-13
Thyroxine Thyroxine Cancer Institute and Hospital, Chinese Academy of Medical Sciences marketed THAP domain-containing protein 1, Macrophage migration inhibitory factor, Malate dehydrogenase, mitochondrial

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). levothyroxin — Competitive Intelligence Brief. https://druglandscape.com/ci/levothyroxin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: